FDA says “Bayesian” statistical methods will get devices to market faster
This article was originally published in Clinica
Executive Summary
Anyone in the medtech industry who has not heard of the 18th century statistician Thomas Bayes will be hearing a lot more about him – or at least his work – in the future.